Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Bioscience (Scholar Edition)|December 8, 2021
Anti PD-L1 antibody: is there a histologic-oriented efficacy? Focus on atezolizumab in squamous cell non-small cell lung cancerMaria Gemelli, Paolo Bidoli, Francesca Colonese, et al.
Immunotherapy|July 11, 2023
Immune-related gigantomastia: a case studyAlessia Lozito, Maria Gemelli, Donata Micello, et al.
Current Drug Targets|December 9, 2014
Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cellsLeticia G Leon, Maria Gemelli, Rocco Sciarrillo, et al.
Frontiers in Oncology|June 17, 2022
Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung CancerMaria Gemelli, Douglas M Noonan, Valentina Carlini, et al.
Expert Review of Anticancer Therapy|April 17, 2024
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLCMaria Gemelli, Adriana Albini, Gianpiero Catalano, et al.
Cancers|December 23, 2022
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-AnalysisMaria Gemelli, Diego Luigi Cortinovis, Alice Baggi, et al.
Cancers|November 25, 2020
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future ProspectsLorenzo Pilla, Andrea Alberti, Pierluigi Di Mauro, et al.
Immunotherapy|December 7, 2021
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literatureMaria Gemelli, Marco Carbone, Maria I Abbate, et al.
Frontiers in Immunology|June 23, 2025
Effect of immune checkpoint inhibitor therapy on biventricular mechanics in cancer patients over a short-term follow-up: a systematic reviewAndrea Sonaglioni, Antonino Bruno, Gian Luigi Nicolosi, et al.
Pageof 3